UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm

Cancer research (Chicago, Ill.), 2015-12, Vol.75 (24), p.5329-5340

2015

Volltextzugriff (PDF)

Characterization of ritonavir-mediated inactivation of cytochrome P450 3A4

Molecular pharmacology, 2014-12, Vol.86 (6), p.665-674

2014

Volltextzugriff (PDF)

Effects of interleukin-6 (IL-6) and an anti-IL-6 monoclonal antibody on drug-metabolizing enzymes in human hepatocyte culture

Drug metabolism and disposition, 2011-08, Vol.39 (8), p.1415-1422

2011

Volltextzugriff (PDF)

Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid Leukemia

Molecular cancer therapeutics, 2020-09, Vol.19 (9), p.1875-1888

2020

Volltextzugriff (PDF)

Selection of alternative CYP3A4 probe substrates for clinical drug interaction studies using in vitro data and in vivo simulation

Drug metabolism and disposition, 2010-06, Vol.38 (6), p.981-987

2010

Volltextzugriff (PDF)

Computational Analysis of Cytokine Release Following Bispecific T-Cell Engager Therapy: Applications of a Logic-Based Model

Frontiers in oncology, 2022-03, Vol.12, p.818641-818641

2022

Volltextzugriff (PDF)

Small molecule quantification by liquid chromatography-mass spectrometry for metabolites of drugs and drug candidates

Drug metabolism and disposition, 2011-12, Vol.39 (12), p.2355-2360

2011

Volltextzugriff (PDF)

Prediction of CYP2D6 drug interactions from in vitro data: evidence for substrate-dependent inhibition

Drug metabolism and disposition, 2012-01, Vol.40 (1), p.47-53

2012

Volltextzugriff (PDF)

Characterization of the active site properties of CYP4F12

Drug metabolism and disposition, 2014-10, Vol.42 (10), p.1698-1707

2014

Volltextzugriff (PDF)

Evaluation of CYP2C8 inhibition in vitro: utility of montelukast as a selective CYP2C8 probe substrate

Drug metabolism and disposition, 2011-09, Vol.39 (9), p.1546-1554

2011

Volltextzugriff (PDF)

Preclinical characterization of the ADME properties of a surrogate anti-IL-36R monoclonal antibody antagonist in mouse serum and tissues

mAbs, 2020-01, Vol.12 (1), p.1746520

2020

Volltextzugriff (PDF)

CYP2C9 inhibition: impact of probe selection and pharmacogenetics on in vitro inhibition profiles

Drug metabolism and disposition, 2006-12, Vol.34 (12), p.1966-1975

2006

Volltextzugriff (PDF)

Absolute Quantification of Aldehyde Oxidase Protein in Human Liver Using Liquid Chromatography–Tandem Mass Spectrometry

Molecular pharmaceutics, 2013-10, Vol.10 (10), p.3842-3849

2013

Volltextzugriff (PDF)

Intact mass analysis of monoclonal antibodies by capillary electrophoresis—Mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2016-02, Vol.1011, p.24-32

2016

Volltextzugriff (PDF)

Mechanism-based inactivation of cytochrome P450 3A4 by mibefradil through heme destruction

Drug metabolism and disposition, 2011-07, Vol.39 (7), p.1188-1195

2011

Volltextzugriff (PDF)

Universal Automated Immunoaffinity Purification-CE−MS Platform for Accelerating Next Generation Biologic Design

Analytical chemistry (Washington), 2021-04, Vol.93 (13), p.5562-5569

2021

Volltextzugriff (PDF)

Formation of the Active Species of Cytochrome P450 by Using Iodosylbenzene: A Case for Spin-Selective Reactivity

Chemistry : a European journal, 2007-01, Vol.13 (14), p.4103-4115

2007

Volltextzugriff (PDF)

Immuno-affinity Capture Followed by TMPP N‑Terminus Tagging to Study Catabolism of Therapeutic Proteins

Journal of proteome research, 2017-02, Vol.16 (2), p.911-919

2017

Volltextzugriff (PDF)

The biodistribution of therapeutic proteins: Mechanism, implications for pharmacokinetics, and methods of evaluation

Pharmacology & therapeutics (Oxford), 2020-08, Vol.212, p.107574, Article 107574

2020

Volltextzugriff (PDF)

Deciphering the Exact Sequence of Endogenous Soluble B Cell Maturation Antigen and Unbiased Quantitation in Multiple Myeloma Patient Samples by LC-MS

Clinical chemistry (Baltimore, Md.), 2024-01, Vol.70 (1), p.339-349

2024

Volltextzugriff (PDF)

In vitro inhibition of multiple cytochrome P450 isoforms by xanthone derivatives from mangosteen extract

Drug metabolism and disposition, 2009-09, Vol.37 (9), p.1848-1855

2009

Volltextzugriff (PDF)

Enzyme source effects on CYP2C9 kinetics and inhibition

Drug metabolism and disposition, 2006-11, Vol.34 (11), p.1903-1908

2006

Volltextzugriff (PDF)

Differential Time-Dependent Inactivation of P450 3A4 and P450 3A5 by Raloxifene: A Key Role for C239 in Quenching Reactive Intermediates

Chemical research in toxicology, 2007-12, Vol.20 (12), p.1778-1786

2007

Volltextzugriff (PDF)

Correlation of In Vitro Kinetic Stability to Preclinical In Vivo Pharmacokinetics for a Panel of Anti-PD-1 Monoclonal Antibody Interleukin 21 Mutein Immunocytokines

Drug metabolism and disposition, 2024-02, Vol.52 (3), p.228

2024

Volltextzugriff (PDF)

Immunoaffinity capture coupled with capillary electrophoresis - mass spectrometry to study therapeutic protein stability in vivo

Analytical biochemistry, 2017-12, Vol.539, p.118-126

2017

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Englisch
(110)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(80)
Life Sciences & Biomedicine
(74)
Humans
(45)
Pharmacology & Pharmacy
(35)
Biochemistry & Molecular Biology
(19)
Biological And Medical Sciences
(17)
Animals
(16)
Medical Sciences
(15)
Kinetics
(14)
Physical Sciences
(14)
Chemistry
(13)
Cytochrome P-450 Enzyme System - Metabolism
(13)
Female
(13)
Male
(13)
Pharmacology. Drug Treatments
(11)
Biochemical Research Methods
(9)
Adult
(8)
Cytochrome P-450 Cyp3a - Metabolism
(8)
Mass Spectrometry
(8)
Microsomes, Liver - Enzymology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm

Characterization of ritonavir-mediated inactivation of cytochrome P450 3A4

Effects of interleukin-6 (IL-6) and an anti-IL-6 monoclonal antibody on drug-metabolizing enzymes in human hepatocyte culture

Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid Leukemia

Selection of alternative CYP3A4 probe substrates for clinical drug interaction studies using in vitro data and in vivo simulation

Computational Analysis of Cytokine Release Following Bispecific T-Cell Engager Therapy: Applications of a Logic-Based Model

Small molecule quantification by liquid chromatography-mass spectrometry for metabolites of drugs and drug candidates

Prediction of CYP2D6 drug interactions from in vitro data: evidence for substrate-dependent inhibition

Characterization of the active site properties of CYP4F12

Evaluation of CYP2C8 inhibition in vitro: utility of montelukast as a selective CYP2C8 probe substrate

Preclinical characterization of the ADME properties of a surrogate anti-IL-36R monoclonal antibody antagonist in mouse serum and tissues

CYP2C9 inhibition: impact of probe selection and pharmacogenetics on in vitro inhibition profiles

Absolute Quantification of Aldehyde Oxidase Protein in Human Liver Using Liquid Chromatography–Tandem Mass Spectrometry

Intact mass analysis of monoclonal antibodies by capillary electrophoresis—Mass spectrometry

Mechanism-based inactivation of cytochrome P450 3A4 by mibefradil through heme destruction

Universal Automated Immunoaffinity Purification-CE−MS Platform for Accelerating Next Generation Biologic Design

Formation of the Active Species of Cytochrome P450 by Using Iodosylbenzene: A Case for Spin-Selective Reactivity

Immuno-affinity Capture Followed by TMPP N‑Terminus Tagging to Study Catabolism of Therapeutic Proteins

The biodistribution of therapeutic proteins: Mechanism, implications for pharmacokinetics, and methods of evaluation

Deciphering the Exact Sequence of Endogenous Soluble B Cell Maturation Antigen and Unbiased Quantitation in Multiple Myeloma Patient Samples by LC-MS

In vitro inhibition of multiple cytochrome P450 isoforms by xanthone derivatives from mangosteen extract

Enzyme source effects on CYP2C9 kinetics and inhibition

Differential Time-Dependent Inactivation of P450 3A4 and P450 3A5 by Raloxifene: A Key Role for C239 in Quenching Reactive Intermediates

Correlation of In Vitro Kinetic Stability to Preclinical In Vivo Pharmacokinetics for a Panel of Anti-PD-1 Monoclonal Antibody Interleukin 21 Mutein Immunocytokines

Immunoaffinity capture coupled with capillary electrophoresis - mass spectrometry to study therapeutic protein stability in vivo

Suchergebnisse filtern